Myanmar vs United States of America: New cases tested for RR-/MDR-TB
Myanmar
91.0%
in 2024
United States of America
91.0%
in 2023
Myanmar rank
91st
United States of America rank
91st
New cases tested for RR-/MDR-TB over time
- Myanmar
- United States of America
How they compare
Myanmar currently reports 91.0% against 91.0% in United States of America, a difference of 0.0%.
The two have swapped places 2 times across 11 shared years of data; in 2012 it was United States of America ahead.
Myanmar ranks 91st and United States of America ranks 91st of 192 countries.
United States of America has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Myanmar | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 43.8% | 98.0% | 54.2% | United States of America |
| 2020s | 81.7% | 93.0% | 11.3% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Myanmar or United States of America?
- Myanmar, at 91.0% against 91.0% in United States of America as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Myanmar and United States of America?
- 0.0%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and United States of America?
- 11 years are reported by both, from 2012 to 2023.
- How do Myanmar and United States of America rank globally for new cases tested for rr-/mdr-tb?
- Myanmar ranks 91st and United States of America ranks 91st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.